These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2486304)

  • 1. Kala-azar mortality in hospitalized cases in north Bihar, India.
    Singh NK; Sharma D; Jha TK
    J Assoc Physicians India; 1989 Aug; 37(8):514-6. PubMed ID: 2486304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kala azar mortality in hospital cases in north Bihar, India.
    Sahay BK
    J Assoc Physicians India; 1990 Jun; 38(6):453. PubMed ID: 2384475
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deaths in visceral leishmaniasis (Kala-azar) during treatment.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Azad KA
    Med J Malaysia; 1996 Mar; 51(1):29-32. PubMed ID: 10967976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with amphotericin B in sodium stibogluconate--unresponsive cases of visceral Leishmaniasis in north Bihar.
    Giri OP; Singh AN
    J Assoc Physicians India; 1994 Sep; 42(9):690-1. PubMed ID: 7883660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kala-azar control programme for remote tribal communities.
    Thakur CP; Frances Sister ; Therese Sister ; Victoria Sister ; Puspa Sister
    World Health Forum; 1994; 15(3):245-7. PubMed ID: 7945751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
    Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in age incidence of kala-azar in India.
    Basu D; Mallik KK
    Indian J Public Health; 1995; 39(1):26. PubMed ID: 8690477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral leishmaniasis control in India through primary health care system--a successful experiment of district level planning.
    Saxena NB; Aggarwal V; Dhillon GP; Sharma RS; Rao JS
    J Commun Dis; 1996 Jun; 28(2):122-8. PubMed ID: 8810148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile of kala-azar in north Bihar.
    Barat D; Bhattacharya PK
    J Indian Med Assoc; 1986 Dec; 84(12):367-9. PubMed ID: 3585012
    [No Abstract]   [Full Text] [Related]  

  • 14. A report on the indoor residual spraying (IRS) in the control of Phlebotomus argentipes, the vector of visceral leishmaniasis in Bihar (India): an initiative towards total elimination targeting 2015 (Series-1).
    Kumar V; Kesari S; Dinesh DS; Tiwari AK; Kumar AJ; Kumar R; Singh VP; Das P
    J Vector Borne Dis; 2009 Sep; 46(3):225-9. PubMed ID: 19724087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profile of cases of kala-azar in Bihar.
    Aikat BK; Sahaya S; Pathania AG; Bhattacharya PK; Desai N; Prasad LS; Mishra S; Jain S
    Indian J Med Res; 1979 Oct; 70():563-70. PubMed ID: 541003
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis (kala-azar)--the Bihar (India) perspective.
    Sinha PK; Ranjan A; Singh VP; Das VN; Pandey K; Kumar N; Verma N; Lal CS; Sur D; Manna B; Bhattacharya SK
    J Infect; 2006 Jul; 53(1):60-4. PubMed ID: 16269185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis (kala-azar) in Fars Province, Iran: study of 130 cases.
    Hashemi-Nasab A; Zadeh-Shirazi H
    J Trop Med Hyg; 1980 Jun; 83(3):119-22. PubMed ID: 7401218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with roxithromycin in visceral leishmaniasis in north Bihar.
    Lal SK; Lal R; Lal S; Lal R; Lal BN
    J Assoc Physicians India; 1996 Sep; 44(9):615-7. PubMed ID: 9251373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission dynamics and underreporting of Kala-azar in the Indian state of Bihar.
    Mubayi A; Castillo-Chavez C; Chowell G; Kribs-Zaleta C; Ali Siddiqui N; Kumar N; Das P
    J Theor Biol; 2010 Jan; 262(1):177-85. PubMed ID: 19769990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.